A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients

  title={A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients},
  author={Mohamed T. Khayyal and Mona A El-Ghazaly and Aiman S. El‐Khatib and Ashraf Hatem and Peter J. de Vries and Samah M. S. El-Shafei and Mahmoud Mohamed Khattab},
  journal={Fundamental \& Clinical Pharmacology},
The aqueous extract of propolis has been formulated as a nutritional food product and administered, as an adjuvant to therapy, to patients with mild to moderate asthma daily for 2 months in the framework of a comparative clinical study in parallel with a placebo preparation. The diagnosis of asthma was made according to the criteria of patient classification of the National Institutes of Health and Global Initiative for Asthma Management. At inclusion, the pulmonary forced expiratory volume in… 

Anti-Allergic Properties of Propolis: Evidence From Preclinical and Clinical Studies

This mini-review summarizes and discusses existing preclinical and clinical studies reporting the anti-allergic activities of propolis to provide insights into its potential applications in allergic diseases.

Factorial analysis of N-acetylcysteine and propolis treatment effects on symptoms, life quality and exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD): a randomized, double-blind, placebo-controlled trial.

Treatment with high NACp for 6 months is safe and beneficial for cough and expectoration symptoms and improves the life quality.

The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases

This review systematically compiles, for the first time, the existing preclinical and clinical evidence of propolis activities as an antiviral and immunomodulatory agent, focusing on the possible application in respiratory diseases.

Diet effects in the asthma treatment: A systematic review

The evidence shows that, for obese adults with asthma, the best dietary intervention seems to be caloric restriction, regardless of specific dietary components.

A novel herbal composition containing extracts of Boswellia serrata gum resin and Aegle marmelos fruit alleviates symptoms of asthma in a placebo controlled double‐blind clinical study

Observations suggest that LI13109F (AlvioLife®) is tolerable and an effective intervention for management of mild to moderate asthma such as airway inflammation.

Herbal interventions for chronic asthma in adults and children.

Positive findings in this review warrant additional well-designed trials in this area, and the evidence base for the effects of herbal treatments is hampered by the variety of treatments assessed, poor reporting quality of the studies and lack of available data.

A review of the potential therapeutic and cosmetic use of propolis in topical formulations

This literature review will focus on propolis composition and related potential uses in topical pharmaceutical and cosmetic formulations.

Propolis: is there a potential for the development of new drugs?

Complementary/Alternative Therapies in Asthma

There is as yet no conclusive evidence of effectiveness in the treatment of asthma for any botanical, and the authors suggest a healthy well-balanced diet with high intake of fruits and vegetables rich in antioxidant vitamins, flavonoids, and minerals.

Mechanisms involved in the antiinflammatory effect of propolis extract.

It is concluded that propolis extract has potent antiinflammatory properties in vivo and its activity can be well correlated with its effects on the release of various mediators of inflammation.

Effect of inhaled prostaglandin E2 on allergen-induced asthma.

PGE2 caused marked inhibition of the early and late response to allergen, which was examined in a double-blind crossover study of eight subjects with asthma.

Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients.

Diftalone, a new non-steroid anti-inflammatory agent, was well tolerated in 9 aspirin-intolerant asthmatic patients, and did not modify the bronchial response to PGF2alpha which was found to be generally lower then that of other aspirin-tolerant patients.

Clinical, functional and pathogenetic aspects of bronchial reactivity to prostaglandins F2alpha, E1, and E2.

It is reassuring that, even in the absence of a demonstrable bronchodilator effect, both PGE1 and PGE2 are capable to prevent in a large degree the specifically and nonspecifically induced bronchospasm.

The use of aqueous propolis extract against radiation-induced damage.

Aqueous propolis extract could possibly be of therapeutic value in protecting against inflammatory responses induced by gamma radiation, and stimulated the release of superoxide dismutase enzyme.

Biochemical Activities of Propolis Extracts. I. Standardization and Antioxidative Properties of Ethanolic and Aqueous Derivatives

Water-soluble extracts of propolis exhibit higher antioxidative and inhibitory activities as compared to the ethanolic extract, and simple biochemical "activity" tests indicate the presence of a defined mixture of monophenolic and diphenolic compounds.

Circulating adhesion molecules in bronchial asthma.

The clinical utility of serum soluble levels of adhesion molecules do not appear to be a useful marker for monitoring the persistent inflammatory activity in stable bronchial asthma.

Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs.

Antigen-induced airway hyperresponsiveness in dogs may depend upon the thromboxane A2 generation from inflammatory cells (e.g., neutrophils).